CGRP and migraine

Por Cauchi, M., Robertson, N. P.
Publicado no J Neurol (2016)

Zika virus and neurology: proving cause and effect

Por Massey, T. H., Robertson, N. P.
Publicado no J Neurol (2016)

Why antisense could make sense for neurodegeneration

Por Massey, T. H., Robertson, N. P.
Publicado no J Neurol (2017)

Repurposing drugs to treat neurological diseases

Por Massey, T. H., Robertson, N. P.
Publicado no J Neurol (2018)

Continuous evolution of magnetic resonance imaging in multiple sclerosis

Por Tallantyre, E. C., Robertson, N. P.
Publicado no J Neurol (2016)

Reversing the trend: interventions to treat intracranial haemorrhage associated with anticoagulation

Por McLauchlan, D., Robertson, N. P.
Publicado no J Neurol (2016)

Treatments in Alzheimer’s disease

Por Malik, G. A., Robertson, N. P.
Publicado no J Neurol (2017)

Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms

Por Peall, K. J., Robertson, N. P.
Publicado no J Neurol (2017)

B cell treatments for multiple sclerosis

Por McLauchlan, D., Robertson, N. P.
Publicado no J Neurol (2017)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics

Por Al-Ansari, Aseel, Robertson, N. P.
Publicado no J Neurol (2017)

Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis

Por Willis, M. D., Robertson, N. P.
Publicado no J Neurol (2017)

The economic burden of chronic neurological disease

Por Wynford-Thomas, R., Robertson, N. P.
Publicado no J Neurol (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

Por Willis, M. D., Robertson, N. P.
Publicado no J Neurol (2018)

Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

Por Willis, M. D., Robertson, N. P.
Publicado no J Neurol (2018)

Anti-epileptics and pregnancy: an update

Por Al-Ansari, A., Robertson, N. P.
Publicado no J Neurol (2018)

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Por Ingram, G, Hakobyan, S, Robertson, N P, Morgan, B P
Publicado em 2009

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment

Por McLauchlan, D., Malik, G. A., Robertson, N. P.
Publicado no J Neurol (2017)

Cytotoxic and hemolytic effects of Tritrichomonas foetus on mammalian cells.

Por Burgess, D E, Knoblock, K F, Daugherty, T, Robertson, N P
Publicado em 1990

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

Por Tallantyre, E. C., Whittam, D. H., Jolles, S., Paling, D., Constantinesecu, C., Robertson, N. P., Jacob, A.
Publicado no J Neurol (2018)

Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

Por Tallantyre, E. C., Whittam, D. H., Jolles, S., Paling, D., Constantinescu, C., Robertson, N. P., Jacob, A.
Publicado no J Neurol (2018)